Skip to main content


Everolimus-Eluting Platinum Chromium Coronary Stent System

PLATINUM Workhorse Trial

Platform Matters

The Promus PREMIER Stent's PtCr alloy, combined with a unique customized architecture, provides exceptional results with less vessel straightening and increased stent fracture resistance.

Platinum Chromium Everolimus-Eluting Clinical Experience

Study Objective: Evaluate the safety and effectiveness of the Promus Platinum Chromium (PtCr) EES Stent System* for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the Xience Cobalt Chromium (CoCr) EES Stent

Study Design: Prospective, Randomized, Controlled, Non-inferiority, Multicenter

Numerically Lower Ischemia-Driven TLR1

5-Year Clinical Results

Numerically lower ischemia-driven TLR with platinum chromium stent

Significant Reduction In Unplanned Bail-out Stenting = $116 Savings / Procedure2,3

1-Year Results

Reduced unplanned bail-out stenting with platinum chromium stent

Numerically Lower Event Rates1

5-Year Clinical Results

Lower event rate with platinum chromium stent